CSL Behring Scoops Up This U.S. Biotech for $416 Million Post author:Sam Post published:August 27, 2017 Post category:BioPharma August 28, 2017By Mark Terry, BioSpace.com Breaking News StaffMelbourne, Australia… Source: BioSpace You Might Also Like Why 90% of This $26 Billion Biotech's Sales Could be At Risk Within the Next 2 Years April 20, 2017 Genentech New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche Stock Soars March 1, 2017 Why Celgene Should Consider Buying Rival Biogen January 23, 2017